Skip to main content Back to Top
Advertisement

7/2/2022

Esmolol Injection

Products Affected - Description

    • Esmolol, AuroMedics, 10 mg/mL, 10 mL preservative-free vial, 25 count, NDC 55150-0194-10
    • Esmolol, Sagent, 10 mg/mL, 10 mL preservative-free vial, 10 count, NDC 25021-0314-10

Reason for the Shortage

    • AuroMedics did not provide a reason for the shortage.
    • Baxter has esmolol injection available.
    • Fresenius Kabi has esmolol injection available.
    • Mylan Institutional has esmolol injection available
    • Sagent did not provide a reason for the shortage.
    • WGCC has esmolol injection available.

Available Products

    • Brevibloc, Baxter, 10 mg/mL, 10 mL preservative-free vial, 25 count, NDC 01001-9115-01
    • Brevibloc, Baxter, 10 mg/mL, 250 mL premixed bag, 10 count, NDC 01001-9055-61
    • Brevibloc, Baxter, 20 mg/mL, 100 mL premixed bag, 10 count, NDC 01001-9075-87
    • Esmolol, Baxter, 10 mg/mL, 10 mL preservative-free vial, 25 count, NDC 01001-9120-01
    • Esmolol, Fresenius Kabi, 10 mg/mL, 10 mL preservative-free vial, 25 count, NDC 63323-0652-10
    • Esmolol, Mylan Institutional, 10 mg/mL, 10 mL preservative-free vial, 10 count, NDC 67457-0182-10
    • Esmolol, Mylan Institutional, 10 mg/mL, 250 mL premixed bag, 10 count, NDC 67457-0657-25
    • Esmolol, Mylan Institutional, 20 mg/mL, 100 mL premixed bag, 10 count, NDC 67457-0685-10
    • Esmolol, Sagent, 10 mg/mL, 250 mL premixed bag, 10 count, NDC 25021-0308-84
    • Esmolol, Sagent, 20 mg/mL, 100 mL premixed bag, 10 count, NDC 25021-0309-82
    • Esmolol, WG Critical Care, 10 mg/mL, 250 mL premixed bag, 10 count, NDC 44567-0811-10
    • Esmolol, WG Critical Care, 20 mg/mL, 100 mL premixed bag, 10 count, NDC 44567-0812-10

Estimated Resupply Dates

    • AuroMedics has esmolol 10 mg/mL 10 mL vials on intermittent back order and the company is releasing product as it becomes available.
    • Sagent has esmolol 10 mg/mL 10 mL vials on back order and the company cannot estimate a release date.

Updated

Updated July 2, 2022 by Elyse MacDonald, PharmD, MS, BCPS. Created January 28, 2022 by Michelle Wheeler, PharmD, Drug Information Specialist. © 2022, Drug Information Service, University of Utah, Salt Lake City, UT.

ADVERTISEMENT

Disclaimer

Drug Shortage Bulletins are copyrighted by the Drug Information Service of the University of Utah and provided by ASHP as its exclusive authorized distributor. ASHP and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, with respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this Bulletin. Neither ASHP nor the University of Utah endorses or recommends the use of any particular drug. Any application of this information for any purpose shall be limited to personal, non-commercial use.

« Back to Drug Shortage Product Bulletins


ahfs logo

Subscribe to AHFS Clinical Drug Information to get direct access to integrated drug shortages content, plus comprehensive and actionable drug information.